Skip to content

Randomized Comparison of IVUS-guided and FFR-guided Stenting for non-LM True Coronary Bifurcation Lesions

Randomized Comparison of IVUS-guided and FFR-guided Stenting for non-LM True Coronary Bifurcation Lesions

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-16008165
Enrollment
Unknown
Registered
2016-03-27
Start date
2016-05-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

coronary heart disease

Interventions

IVUS-guided Group:IVUS-guided PCI
FFR-guided Group:FFR-guided PCI

Sponsors

Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 75 year; 2. Patients with typical angina symptoms, but respond poorly to drug treatment; 3. Medina 1,1,1/0,1,1 bifurcation lesions; 4. Side branch >=2.5 mm in diameter; 5. Lesion length in each side branch could be covered by 2 DESs; 6. Signed informed consent.

Exclusion criteria

Exclusion criteria: 1. MI 3 mg/dl, or eGFR <40 ml/min/1.73 m2; 11. With dilated cardiomyopathy, hypertrophic cardiomyopathy, severe valvular heart disease or other severe systemic diseases; 12. Patient is taking or will take large doses of glucocorticoid; 13. Patient with malignant tumor; 14. Expected lifespan of <1 year; 15. Women of childbearing age but without proper contraceptive measures or pregnancy; 16. Researchers believe that patient don't fit into the group.

Design outcomes

Primary

MeasureTime frame
major adverse cardiac events;Procedure success rate;

Secondary

MeasureTime frame
TVR;TLR;

Countries

China

Contacts

Public ContactZhou Binquan

Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University

benzhou@hotmail.com+86 15858127826

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026